CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Endpoints 11 2026 winner Kali looked at China for pipeline drugs, then turned in-house

Neutral
AI Analysis

Summary

Kali, an Endpoints 11 2026 winner, initially explored acquiring pipeline drugs from China but subsequently shifted strategy to develop drugs in-house.

Importance:2/10
Sentiment:
0.00
pipeline strategyChinain-house development
Related Companies

Read the original article

Published by Endpoints News on September 25, 2026 2:00 PM

Read Original